Summary. The development and proliferation of trophoblast from ectopic mouse embryo allografts and isografts of increasing gestational age in nonimmune and specifically preimmunized hosts was studied. Specific preimmunization of recipients significantly inhibited haemorrhagic nodule development from 3-3\m=1/2\ and 4-4\m=1/2\day post coitum homozygous blastocysts and from 5-5\ m=1/ 2\day homozygous egg cylinders. preimmunization had no effect on the percentage of haemorrhagic nodules which developed from 6-6\m=1/2\day homozygous egg cylinders. Haemorrhagic nodule development was significantly increased for F1 hybrid allografts compared to homozygous allografts to preimmunized recipients. Coincident with the immune inhibition of haemorrhagic nodule formation was the microscopic finding that in some cases trophoblast cells developed without subsequent proliferation in preimmunized hosts.
Introduction
The mammalian fetus is a potential allograft to the mother. It contains genetic information from the father and therefore has the potential for expressing transplantation antigens which the mother could recognize as being foreign. However, despite the expression of histocompatibility antigens by the fetus (Simmons & Russell, 1962; Edidin, 1964;  Schlesinger, 1964; Seigier & Metzgar, 1970;  Patthey & Edidin, 1973) , there is no conclusive evidence that the fetus in utero can be rejected as an allograft by maternal immunocytes.
It has been suggested that there is a physiological immune barrier between the mother and the fetus to prevent allograft rejection of the fetus (Medawar, 1953) . This immunological buffer zone is apparently comprised of trophoblast, a tissue of fetal origin, which forms a continuous boundary between the maternal and fetal placental components. Simmons & Russell (1962 found that preimplantation mouse zygotes were subject to immune destruction as ectopie allografts in speci¬ fically preimmunized recipients. The ectoplacental cone trophoblast tissue, however, was not destroyed as an allograft in similar recipients. Kirby, Billington & James (1966) observed that while 3ì-day post coitum {p.c.) preimplantation mouse blastocysts failed to grow ectopically as allografts in specifically hyperimmunized pseudopregnant female hosts, some blastocysts underwent implantation and developed normally when transferred to the uterine horns of the same recipients. Kirby et al felt that the uterus must therefore act as an immunologically privileged site before and during implantation and that the decidua protected the implanting blastocyst from immune destruction until the trophoblast developed and assumed its role as an immunological buffer zone. Kirby et al (1966) postulated that the trophoblast did not become an effective barrier until 6 days p.c., when a continuous pericellular coating (Kirby, Billington, Bradbury & Goldstein, 1964; Bradbury, Billington & Kirby, 1965) could be detected between the trophoblast and the decidual cells. Beer, Billingham & Hoerr (1971) 
Intermediate host allografts
The results of Exps 6 and 7 ( Table 3 ) further suggest that trophoblastic cell development and proliferation from ectopie embryo allografts when there is pre-existing immunity is dependent upon the attainment of a certain level of embryonic differentiation before transplantation. Homozygous C3H 4-4$-day blastocyst allografts were transplanted beneath the kidney capsules of nonimmune C57 recipients. After 1 or 2 days, the primary recipients were killed, the grafts removed and retransplanted beneath the kidney capsules of secondary recipients pre-hyperimmunized to C3H alloantigens, and the secondary recipients killed after 7 days. The development of 4-4$-day blastocyst allografts for only 24 hr in a nonimmune recipient significantly increased the percentage of haemor¬ rhagic nodules which developed in pre-hyperimmunized hosts. After 48 hr in a nonimmune primary recipient, re-transplantation resulted in haemorrhagic nodule development from virtually all transplants. (James, 1969; James & Yoshida, 1972) . It is unclear at the present time whether the inhibition of trophoblast development from ectopie allografts in preimmunized recipients is the result of a direct immune response against the pretrophoblastic trophectoderm or the indirect result of a rejection of the inner cell mass. The inhibition of trophoblast development from ectopie blastocyst allografts in preimmunized recipients has been attributed to the presence of transplantation antigens on the trophectoderm. While preimplantation mouse blastocysts do not appear to express H-2 alloantigens on the trophectoderm, they do express some non-H-2 transplantation antigens (Palm, Heyner & Brinster, 1971 ). It has also been shown that inhibition of trophoblast development from ectopie mouse blastocyst allografts can occur across donor-recipient combinations which differ solely in non-H-2 alloantigens but not in those differing solely in H-2 (Searle, Johnson, Billington, Elson & Cutterbuck-Jackson, 1974) . It has been suggested that the inhibition of trophoblast development and proliferation in ectopie blastocyst allografts can be explained as an immune rejection of the inner cell mass or its derivatives which are a necessary inductive influence for normal trophoblast ontogeny (Gardner, Johnson & Edwards, 1973) . Gardner (1972) found evidence from intrauterine transplants of mouse blastocyst trophectoderm and/or inner cell mass tissue to indicate that the presence of the latter was critical for trophoblast proliferation. In the absence of the inner cell mass, the trophectoderm gave rise to small numbers of primary trophoblastic giant cells which did not proliferate. These observations were also supported by studies of trophoblast development and proliferation from ectopie mouse blastocyst isografts in the presence or absence of concomitant inner cell mass development (Johnson, 1972 ).
There is evidence that H-2 alloantigens are first expressed on the mouse embryo devoid of tropho¬ blast at Day 7 of gestation (Patthey & Edidin, 1973) , a stage when the embryo is subject to immune rejection both as an ectopie allograft and by immune lymphocytes in vitro (Jenkinson & Billington, 1974) . However, the extent of non-H-2 or low level H-2 alloantigen expression by the inner cell mass or its derivatives before this stage of gestation has not been established.
One of the factors which determines the extent of ectopie trophoblast development and prolifera¬ tion is the interaction between timing of the immune response of the recipient and the amount of embryonic differentiation which can take place before a rejection response. The differences in the extent of trophoblast development associated with the degree of recipient preimmunization which we found (Table 2) indicates that there was differentiation of the transplant in recipients preimmunized with two skin grafts before the host mounted a significant immune rejection response. Searle et al. (1974) found that a marked cellular infiltration associated with an allograft rejection appears in a pre-hyperimmunized host 48-72 hr after an ectopie blastocyst allograft. A longer response interval would be expected after a lesser degree of preimmunization and would allow more time for embryonic differentiation to continue.
Another factor involved in the ectopie development and proliferation of the trophoblast appears to be the level of antigen expression by the transplant. In the present study, evidence was found which indicated that ectopie hybrid allografts were more resistant than homozygous allografts of comparable gestational age to an immune inhibition of trophoblast development. Simmons & Russell (1966) (1972) and Johnson (1972) . Microscopic examination of these grafts revealed an intense cellular infiltration throughout the entire graft. Since ectopie allografts of pure trophoblast are not associated with cellular infiltration in preimmunized hosts (Simmons & Russell, 1966) , the finding of infiltration suggests an immune response to other embryonic tissues in the transplant. This immune suppression of trophoblast proliferation may represent the arrest of tropho¬ blast ontogeny as a result of immune rejection of the inner cell mass.
The results of the present study indicate that the earliest stage of mouse trophoblast ontogeny at which the trophoblast can continue to develop and proliferate when transplanted to an ectopie pre-hyperimmunized environment, i.e. before a rejection response, is not reached until the last stage of the implantation period, 5-6$ days p.c. This time may reflect the stage of trophoblast ontogeny at which the inductive influences of the inner cell mass are no longer necessary or can take place before immune rejection of the inner cell mass or its dissolution in an ectopie environment. Our studies would seem to support the contention of Kirby et al (1966) that the uterine milieu may provide an as yet undefined protective influence against a maternal allograft rejection of the conceptus before and during implantation.
